SH

Sayed Hassan Bafakyh

Active Director Director DIN 10421897
DIN 10421897 First appointment Dec 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sayed Hassan Bafakyh

Data last updated:

Sayed Hassan Bafakyh is a Director at Bafakyh Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10421897
Primary Designation Director
Industry Pharma
First Appointment 11 Dec 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Dec 20232023Active

Board colleagues of Sayed Hassan Bafakyh

NameDINCompanyDesignation
Sayed Abdurahiman Shabab Bafakyh10421898Bafakyh Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Bafakyh Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sayed Hassan Bafakyh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sayed Hassan Bafakyh

Sayed Hassan Bafakyh currently holds 1 directorship: Bafakyh Pharmaceuticals Private Limited (Director, since 11 Dec 2023).

Sayed Hassan Bafakyh was first appointed on 11 Dec 2023 as Director at Bafakyh Pharmaceuticals Private Limited.

The current boards of Sayed Hassan Bafakyh's companies include Sayed Abdurahiman Shabab Bafakyh (Bafakyh Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available